foenumoside B

an anti-adipogenic agent isolated from Lysimachia foenum-graecum; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Shock 08/05/2018 - "Foenumoside B isolated from Lysimachia foenum-graecum extract suppresses LPS-induced inflammatory response via NF-κB/AP-1 inactivation in murine macrophages and in endotoxin-induced shock model."
2.	Obesity 01/13/2012 - "Taken together, these findings demonstrate that foenumoside B represents the anti-obesity effects of L. " 01/13/2012 - "Foenumoside B from Lysimachia foenum-graecum inhibits adipocyte differentiation and obesity induced by high-fat diet." 01/13/2012 - "foenum-graecum, and suggest therapeutic potential of foenumoside B in obesity and obesity-related metabolic diseases."
3.	Metabolic Diseases (Metabolic Disease) 01/13/2012 - "foenum-graecum, and suggest therapeutic potential of foenumoside B in obesity and obesity-related metabolic diseases."
4.	Insulin Resistance 01/13/2012 - "Foenumoside B also blocked HFD-induced proinflammatory cytokine production in adipose tissue, suggesting its protective role against insulin resistance. "
5.	Body Weight (Weight, Body) 01/13/2012 - "In mouse model, oral administration of foenumoside B (10mg/kg/day for 6 weeks) reduced HFD-induced body weight gain significantly without affecting food intake. "

1.	Oral Administration